Literature DB >> 23458879

Cell cycle arrest in Batten disease lymphoblast cells.

Sunyang Kang1, June-Bum Kim, Tae-Hwe Heo, Sung-Jo Kim.   

Abstract

Batten disease is an inherited neurodegenerative disorder caused by a CLN3 gene mutation. Batten disease is characterized by blindness, seizures, cognitive decline, and early death. Although apoptotic cell death is one of the pathological hallmarks of Batten disease, little is known about the regulatory mechanism of apoptosis in this disease. Since the CLN3 gene is suggested to be involved in the cell cycle in a yeast model, we investigated the cell cycle profile and its regulatory factors in lymphoblast cells from Batten disease patients. We found G1/G0 cell cycle arrest in Batten disease cells, with overexpression of p21, sphingosine, glucosylceramide, and sulfatide as possible cell cycle regulators.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458879     DOI: 10.1016/j.gene.2013.02.022

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.

Authors:  Jaime Cárcel-Trullols; Attila D Kovács; David A Pearce
Journal:  J Cell Biochem       Date:  2017-05-23       Impact factor: 4.429

2.  Aberrant adhesion impacts early development in a Dictyostelium model for juvenile neuronal ceroid lipofuscinosis.

Authors:  Robert J Huber; Michael A Myre; Susan L Cotman
Journal:  Cell Adh Migr       Date:  2016-09-26       Impact factor: 3.405

3.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

4.  Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.

Authors:  Tarah Nelson; David A Pearce; Attila D Kovács
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

5.  Tracking sex-dependent differences in a mouse model of CLN6-Batten disease.

Authors:  McKayla J Poppens; Jacob T Cain; Tyler B Johnson; Katherine A White; Samantha S Davis; Rachel Laufmann; Alexander D Kloth; Jill M Weimer
Journal:  Orphanet J Rare Dis       Date:  2019-01-21       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.